Skip to content

Effects of oxycodone and sufentanil on pulmonary diffusion function and systemic inflammatory reaction during cardiopulmonary bypass cardiac surgery, a randomized controlled study

Effects of oxycodone and sufentanil on pulmonary diffusion function and systemic inflammatory reaction during cardiopulmonary bypass cardiac surgery, a randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071938
Enrollment
Unknown
Registered
2023-05-30
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing extracorporeal circulation cardiac surgery

Interventions

Hydroxycodone group:Oxycodone is used as an opioid during surgery for anesthesia induction and maintenance
Sufentanil group:Sufentanil is used as an opioid during surgery for anesthesia induction and maintenance

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Patients undergoing extracorporeal circulation cardiac surgery; 2) ASA is classified as Level II or III; 3) NYHA is classified as Level II or III; 4) Normal preoperative lung function examination; 5) Age<75 years old; 6) No myocardial infarction occurred within the past 3 months; 7) There is no clear history of drug allergy in the past; 8) For the first time undergoing cardiac surgery.

Exclusion criteria

Exclusion criteria: 1) Angiotensin converting enzyme inhibitor therapy; 2) Apply opioid receptor drugs or non steroidal anti-inflammatory drugs and other analgesics 2 weeks before surgery; 3) History of communication barriers or potential psychological illnesses; 4) Severe liver dysfunction (Child Pugh C grade) 5) Severe renal insufficiency (preoperative dialysis)

Design outcomes

Primary

MeasureTime frame
Pulmonary alveolar arterial oxygen partial pressure difference ;C-reactive protein;

Secondary

MeasureTime frame
Plasma Inflammatory Factor Indicators TNF-a;Plasma Inflammatory Factor Indicator IL-6;Plasma Inflammatory Factor Indicator IL-10;Plasma beta arrestin 2;High sensitivity C-reactive protein ;Intraoperative hemodynamic indicators;The use of cardiovascular drugs (number and dosage of drug recommendations);Sedation Index (BIS);Recovery status of patients after extubation (modified Aldrete scoring table);The incidence and timing of postoperative nausea and vomiting in patients;

Countries

China

Contacts

Public ContactYonghao Hou

Qilu Hospital of Shandong University

houyonghao99@163.com+86 135 4531 0080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026